TMCnet News
Reliq Health Technologies, Inc. to Participate in the Lytham Partners Investor Select ConferenceHAMILTON, Ontario, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023. During the event, the company will be participating in a webcasted fireside chat discussion and conducting 1x1 virtual investor meetings. Company Webcast 1x1 Meetings Reliq Health ON BEHALF OF THE BOARD “Dr. Lisa Crossley” CEO and Director For further information please contact: Company Contact US Investor Relations Contact Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Statements Regarding Forward Looking Information We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements. SOURCE: Reliq Health Technologies Inc. |